Literature DB >> 19624615

New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire.

L J D'Orsogna1, A L Amir, Y M Zoet, P M W van der Meer-Prins, A R van der Slik, M G D Kester, M H M Heemskerk, I I N Doxiadis, D L Roelen, F H J Claas.   

Abstract

Accumulating evidence suggests that alloreactive memory T-cells may be generated as a result of viral infection. So far, a suitable tool to define the individual human leukocyte antigen (HLA) cross-reactivity of virus-specific memory T-cells is not available. We therefore aimed to develop a novel system for the detection of cross-reactive alloresponses using single HLA antigen expressing cell lines (SALs) as stimulator. Herein, we generated Epstein-Barr Virus (EBV) EBNA3A specific CD8 memory T-cell clones (HLA-B*0801/FLRGRAYGL peptide restricted) and assayed for alloreactivity against a panel of SALs using interferon-gamma Elispot as readout. Generation of the T-cell clones was performed by single cell sorting based on staining with viral peptide/major histocompatibility complex-specific tetramer. Monoclonality of the T-cell clones was confirmed by T-cell receptor (TCR) polymerase chain reaction analysis. First, we confirmed the previously described alloreactivity of the EBV EBNA3A-specific T-cell clones against SAL-expressing HLA-B*4402. Further screening against the entire panel of SALs also showed additional cross-reactivity against SAL-expressing HLA-B*5501. Functionality of the cross-reactive T-cell clones was confirmed by chromium release assay using phytohemagglutinin blasts as targets. SALs are an effective tool to detect cross-reactivity of viral-specific CD8 memory T-cell clones against individual class I HLA molecules. This technique may have important implications for donor selection and monitoring of transplant recipients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19624615     DOI: 10.1111/j.1399-0039.2009.01311.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  12 in total

Review 1.  TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition.

Authors:  L J D'Orsogna; D L Roelen; I I N Doxiadis; F H J Claas
Journal:  Immunogenetics       Date:  2011-12-03       Impact factor: 2.846

2.  Detection of Virus-Specific CD8+ T Cells With Cross-Reactivity Against Alloantigens: Potency and Flaws of Present Experimental Methods.

Authors:  Heleen van den Heuvel; Kirstin M Heutinck; Ellen P M W van der Meer-Prins; Si La Yong; Frans H J Claas; Ineke J M Ten Berge
Journal:  Transplant Direct       Date:  2015-11-04

Review 3.  Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms.

Authors:  Lloyd D'Orsogna; Heleen van den Heuvel; Cees van Kooten; Sebastiaan Heidt; Frans H J Claas
Journal:  Immunogenetics       Date:  2017-07-17       Impact factor: 2.846

4.  Cross-Reactivity of Virus-Specific CD8+ T Cells Against Allogeneic HLA-C: Possible Implications for Pregnancy Outcome.

Authors:  Anita van der Zwan; Ellen M W van der Meer-Prins; Paula P M C van Miert; Heleen van den Heuvel; Jacqueline D H Anholts; Dave L Roelen; Frans H J Claas; Sebastiaan Heidt
Journal:  Front Immunol       Date:  2018-12-06       Impact factor: 7.561

5.  Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant.

Authors:  Ulrike Gerdemann; Usha L Katari; Anastasia Papadopoulou; Jacqueline M Keirnan; John A Craddock; Hao Liu; Caridad A Martinez; Alana Kennedy-Nasser; Kathryn S Leung; Stephen M Gottschalk; Robert A Krance; Malcolm K Brenner; Cliona M Rooney; Helen E Heslop; Ann M Leen
Journal:  Mol Ther       Date:  2013-06-20       Impact factor: 11.454

6.  Relatively low level of antigen-specific monocytes detected in blood from untreated tuberculosis patients using CD4+ T-cell receptor tetramers.

Authors:  Yuhong Huang; Yan Huang; Yimin Fang; Juan Wang; Yan Li; Nan Wang; Jianbo Zhang; Ming Gao; Lirong Huang; Fangfang Yang; Cong Wang; Shuxian Lin; Yanan Yao; Liangliang Ren; Yi Chen; Xuanjing Du; Dan Xie; Rongshun Wu; Kouxing Zhang; Lifang Jiang; Xinbing Yu; Xiaomin Lai
Journal:  PLoS Pathog       Date:  2012-11-29       Impact factor: 6.823

7.  Immune parameters to consider when choosing T-cell receptors for therapy.

Authors:  Scott R Burrows; John J Miles
Journal:  Front Immunol       Date:  2013-08-05       Impact factor: 7.561

8.  Cross-reactive anti-viral T cells increase prior to an episode of viral reactivation post human lung transplantation.

Authors:  Thi H O Nguyen; Glen P Westall; Tara E Bull; Aislin C Meehan; Nicole A Mifsud; Tom C Kotsimbos
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

Review 9.  Alloreactivity of virus-specific T cells: possible implication of graft-versus-host disease and graft-versus-leukemia effects.

Authors:  Shigeo Fuji; Markus Kapp; Hermann Einsele
Journal:  Front Immunol       Date:  2013-10-14       Impact factor: 7.561

10.  Mycobacterium tuberculosis peptide E7/HLA-DRB1 tetramers with different HLA-DR alleles bound CD4+ T cells might share identical CDR3 region.

Authors:  Yichuan Gan; Cong Wang; Yimin Fang; Yanan Yao; Xiaoxin Tu; Jiao Wang; Xi Huang; Yaoju Tan; Tao Chen; Kouxing Zhang; Yanming Shen; Lin Zhou; Jianxiong Liu; Xiaomin Lai
Journal:  Sci Rep       Date:  2018-07-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.